<--- Back to Details
First PageDocument Content
Asbestos / Occupational diseases / Mesothelioma / Gene therapy / Thymidine kinase / Jesse Gelsinger / Pleural effusion / Medicine / Health / Biology
Date: 2010-11-17 02:45:42
Asbestos
Occupational diseases
Mesothelioma
Gene therapy
Thymidine kinase
Jesse Gelsinger
Pleural effusion
Medicine
Health
Biology

Excerpt from Letter of Recommendation: After a successful early career in the study of endothelial cell biology and adhesion receptors, Dr. Albelda began his major effort to establish a bench-to-bedside research career,

Add to Reading List

Source URL: imig.org

Download Document from Source Website

File Size: 97,89 KB

Share Document on Facebook

Similar Documents

Cancer Gene Therapy, 587–597 r 2011 Nature America, Inc. All rights reservedwww.nature.com/cgt

Cancer Gene Therapy, 587–597 r 2011 Nature America, Inc. All rights reservedwww.nature.com/cgt

DocID: 1vllG - View Document

Washington University in St. Louis Institutional Biological & Chemical Safety Committee Policy on Severe Adverse Event Reporting for Human Gene Therapy Trials As outlined in Section IV-B-2-b-(1) of the NIH Guidelines for

Washington University in St. Louis Institutional Biological & Chemical Safety Committee Policy on Severe Adverse Event Reporting for Human Gene Therapy Trials As outlined in Section IV-B-2-b-(1) of the NIH Guidelines for

DocID: 1vily - View Document

RARE TOOLKITS ™  A Guide to Gene Therapy Table of Contents Intro to Gene Therapy: Gene Pool

RARE TOOLKITS ™ A Guide to Gene Therapy Table of Contents Intro to Gene Therapy: Gene Pool

DocID: 1v306 - View Document

Pioneering the Development of Safe and Effective Non-Viral Vectors and Processes for Human Gene Therapy and DNA Vaccination. Founded 1999, Clague Hodgson, Ph.D. Chief Scientific Officer, VP, R&D, Jim Williams, Ph.D. (200

Pioneering the Development of Safe and Effective Non-Viral Vectors and Processes for Human Gene Therapy and DNA Vaccination. Founded 1999, Clague Hodgson, Ph.D. Chief Scientific Officer, VP, R&D, Jim Williams, Ph.D. (200

DocID: 1uuzW - View Document

Emily Abrash Final Paper 16 March 2012 Stem Cell Gene Therapy as a Treatment for Diverse Genetic Disorders Mendelian genetic disorders are diverse in their pathophysiology, symptoms, and prognosis, yet have in common the

Emily Abrash Final Paper 16 March 2012 Stem Cell Gene Therapy as a Treatment for Diverse Genetic Disorders Mendelian genetic disorders are diverse in their pathophysiology, symptoms, and prognosis, yet have in common the

DocID: 1uni0 - View Document